← All stocks

Becton Dickinson

BDX Net selling
CIK 0000010795 #66 in the set updated 18 Sep 2026
Bought (120 mo)
$1.55M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$232.47M
$6.81M on a plan · $193.64M straight out of an exercise
Sold at will
$32.02M
52 of 200 sales
Net
−$230.92M
−$30.47M against sales at will

By person

60 insiders · 210 transactions
14.8×

Thomas E. Polen holds 14.8 times base salary in stock. $20.76M of shares against $1.40M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas E. Polen last reported holding, valued at $188.49, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RING TIMOTHY M
Director
$68.73M (8) scheduled
−$68.73M
59,391
0.0218%
$11.19M
−62.9%
FORLENZA VINCENT A
Chairman of the Board
$56.25M (14) scheduled
−$56.25M
194,048
0.0712%
$36.58M
+20.8%
Lim James C
Executive Vice President
$13.58M (9) scheduled
−$13.58M
24,742
0.0091%
$4.66M
+47.4%
SHERMAN JEFFREY S
Sr. VP and General Counsel
$11.01M (3) scheduled
−$11.01M
22,094
0.0081%
$4.16M
−6.9%
Conroy Alexandre
EVP of Integrated Supply Chain
$10.37M (7) scheduled
−$10.37M
21,260
0.0078%
$4.01M
−16.8%
Polen Thomas E Jr
Chairman, CEO and President
$10.24M (12) scheduled
−$10.24M
110,163
0.0404%
$20.76M
+951.1%
Khichi Samrat S.
EVP and General Counsel
$9.04M (4)
−$9.04M
9,251
0.0034%
$1.74M
−71.4%
Mas Ribo Alberto
EVP and Pres, Life Sciences
$7.94M (8) scheduled
−$7.94M
11,662
0.0043%
$2.20M
−26.1%
COHEN GARY M
Executive Vice President
$6.18M (2) scheduled
−$6.18M
71,770
0.0263%
$13.53M
−3.1%
Larson Betty D
EVP HR & CHRO
$5.14M (12) scheduled
−$5.14M
5,872
0.0022%
$1.11M
−44.6%
Sichak Stephen
Executive Vice President
$4.62M (6) scheduled
−$4.62M
7,953
0.0029%
$1.50M
−8.0%
Goette Roland
EVP and President, EMEA
$3.78M (11) scheduled
−$3.78M
14,856
0.0055%
$2.80M
+241.0%
Shabshab Nabil
Executive Vice President
$3.55M (5) scheduled
−$3.55M
7,811
0.0029%
$1.47M
+16.6%
Campion Simon D
EVP and Segment President
$2.99M (6) scheduled
−$2.99M
10,319
0.0038%
$1.95M
−20.6%
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
$2.91M (13) scheduled
−$2.91M
13,172
0.0048%
$2.48M
+69.9%
Borzi James W
EVP & Chief Supply Chain Offcr
$2.40M (7) scheduled
−$2.40M
2,775
0.0010%
$523.06K
+15.4%
Fraser Claire
Director
$1.93M (10)
−$1.93M
22,226
0.0082%
$4.19M
+0.9%
Strahlman Ellen R
Senior Vice President
$1.84M (1) scheduled
−$1.84M
6,898
0.0025%
$1.30M
+187.2%
Byrd Richard
EVP & President Interventional
$1.54M (5) scheduled
−$1.54M
13,849
0.0051%
$2.61M
+134.5%
Gallagher John E
VP, Corp Finance and Treasurer
$1.51M (4) scheduled
−$1.51M
1,975
0.0007%
$372.27K
−39.4%
Hickey David
EVP & President, Life Sciences
$1.20M (4) scheduled
−$1.20M
5,862
0.0022%
$1.10M
+63.9%
Kaltenbach Patrick
EVP & Pres Life Sciences
$1.05M (10)
−$1.05M
10,340
0.0038%
$1.95M
HAYES GREGORY
Director
$1.01M (1)
+$1.01M
7,159
0.0026%
$1.35M
+47,627%
Tharby Linda M
Executive Vice President
$941.25K (1) scheduled
−$941.25K
13,437
0.0049%
$2.53M
+46.2%
Bodner Charles R
SVP Corp Fin Chief Acct Office
$905.09K (3) scheduled
−$905.09K
2,037
0.0007%
$383.95K
+2.0%
Shan David
EVP and Chief ISC Officer
$649.98K (3) scheduled
−$649.98K
8,926
0.0033%
$1.68M
+156.6%
Neal Shana Carol
EVP and Chief People Officer
$594.55K (3) scheduled
−$594.55K
23,966
0.0088%
$4.52M
+561.5%
Spoerel Thomas J
SVPController & Chief Acct Off
$581.88K (7)
−$581.88K
1,928
0.0007%
$363.41K
+63.8%
RIMEL REBECCA W
Director
$424.85K (5)
−$424.85K
10,618
0.0039%
$2.00M
+39.0%
SCOTT BERTRAM L
Director
$371.94K (3)
−$371.94K
36,763
0.0135%
$6.93M
+25.1%
Henderson Jeffrey William
Director
$350.43K (1)
+$350.43K
9,143
0.0034%
$1.72M
+1,625%
Feld Michael
EVP, Chief Revenue Officer
$178.65K (13) scheduled
−$178.65K
19,720
0.0072%
$3.72M
+298.2%
Melcher David F
Director
$112.54K (1)
+$112.54K
6,180
0.0023%
$1.16M
+362.2%
BURZIK CATHERINE M
Director
$82.57K (3)
$10.04K (1)
+$72.54K
14,264
0.0052%
$2.69M
+145.4%
Groetelaars John P
EVP
42,508
0.0156%
$8.01M
+16.9%
Muhsin Bilal
EVP & President Connected Care
41,359
0.0152%
$7.80M
+474.4%
Reidy Christopher R
CFO and EVP of Administration
31,524
0.0116%
$5.94M
+189.5%
OVERLOCK WILARD J JR
Director
28,942
0.0106%
$5.46M
−20.3%
LARSEN MARSHALL O
Director
28,919
0.0106%
$5.45M
+27.9%
Mecklenburg Gary A
Director
25,453
0.0093%
$4.80M
+9.1%
Jones Christopher Ian Montague
Director
24,304
0.0089%
$4.58M
+61.3%
ORR JAMES F
Director
24,257
0.0089%
$4.57M
+5.1%
ANDERSON BASIL
Director
24,148
0.0089%
$4.55M
+5.1%
DelOrefice Christopher
EVP & Chief Financial Officer
22,982
0.0084%
$4.33M
Menziuso Peter
EVP and President, BDI
14,258
0.0052%
$2.69M
TOZZI WILLIAM A
EVP Pres Interventional
12,830
0.0047%
$2.42M
+45.4%
Ezell Antoine C
EVP, President Americas & CMO
11,970
0.0044%
$2.26M
+132.8%
ECKERT R ANDREW
Director
10,423
0.0038%
$1.96M
+1,154%
Pomeroy Claire
Director
9,982
0.0037%
$1.88M
+120.7%
Grover Rishi
EVP and Chief ISC Officer
9,439
0.0035%
$1.78M
+9,434%
Roque Vitor
EVP & Chief Financial Officer
8,041
0.0030%
$1.52M
+44.1%
Minnix Lanesha
EVP and General Counsel
7,492
0.0028%
$1.41M
Quinn Michelle
EVP and General Counsel
6,927
0.0025%
$1.31M
+105.0%
Mocherla Pavan Kumar
EVP & President, Greater Asia
5,763
0.0021%
$1.09M
+712.8%
Byington Carrie L
Director
5,018
0.0018%
$945.84K
+2,397%
Brown William M
Director
4,663
0.0017%
$878.93K
+2,595%
Waldstreicher Joanne
Director
3,391
0.0012%
$639.17K
+7,607%
Spikner Pamela L.
SVP Controller & CAO
3,323
0.0012%
$626.35K
+167.6%
Huffines Robert Luther
Director
1,279
0.0005%
$241.08K
+127,800%
Wright Jacqueline
Director
1,279
0.0005%
$241.08K
+127,800%
Insider
Date
Role
Action
Shares
Price
Amount
Goette Roland
14 Aug 2024
EVP and President EMEA
Exercised, kept
5,295
$132.54
$701.80K
Goette Roland
16 Nov 2023
EVP and President, EMEA
Exercised, kept
3,544
$107.12
$379.63K
Goette Roland
16 Nov 2022
EVP and President, EMEA
Exercised, kept
4,617
$74.94
$346.00K
Goette Roland
16 Nov 2021
EVP and President, EMEA
Exercised, kept
3,055
$72.12
$220.33K

What was left out

Form 4 filings counted 593
Amendments (4/A) skipped 10
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 41
Sales straight out of an exercise 107
Sales at will 52
Transactions with no price 0
Shares from compensation/vesting 3,582,394
Sales filed before the plan box existed 45
History held since 7 Sep 2016